Hans Edgar Bishop - Feb 23, 2022 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Director
Signature
/s/ Heather Turner, as Attorney-in-Fact
Stock symbol
LYEL
Transactions as of
Feb 23, 2022
Transactions value $
$99,343
Form type
4
Date filed
2/25/2022, 03:05 PM
Previous filing
Jun 23, 2021
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYEL Common Stock Options Exercise $99.3K +993K +28.01% $0.10* 4.54M Feb 23, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYEL Option (right to buy) Options Exercise $0 -993K -85.42% $0.00 170K Feb 23, 2022 Common Stock 993K $0.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the option shares vested on September 20, 2019, with the remaining option shares to vest in equal monthly installments over the following thirty-six months. The option provides for an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.